Closed Loop Medicine appoints Paul Johnson as non-executive director

Closed Loop Medicine has announced the appointment of Paul Johnson as an independent non-executive director.
Paul brings with him vast experience in the development and scaling of digital healthcare and e-commerce platforms, having previously co-founded Lemonaid Health and worked as its CEO until it was acquired by 23andMe for $400m in 2021. Paul has also worked as VP and general manager, and later COO, of 23andMe, and head of online at McKesson UK.
Dr Hakim Yadi PhD OBE, CEO and co-founder of Closed Loop Medicine, stated: “As we stand on the brink of realising our vast prospects within the industry, Paul's strategic insights and proven track record will be instrumental to steering the Company to continued growth and success.”
Commenting on his appointment, Paul Johnson said: “Closed Loop Medicine's approach to delivering personalised and integrated healthcare aligns with my commitment to building digital product experiences that treat patients as individuals, rather than an average of a population set. Throughout my career, I've championed digital solutions to prov ide accessible healthcare for all. With its proprietar y dose optimisation platform, the company is going a step further to improve outcomes at the individual level. […] It is clear I am joining Closed Loop Medicine at a very transformative stage in its development, and I am very much looking forward to supporting the company in bringing forward the promise of precision care, as it realises the potential of its product pipeline.”